{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:09Z","timestamp":1790742969420,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2009\/50772-4"],"award-info":[{"award-number":["2009\/50772-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/07231-5"],"award-info":[{"award-number":["2012\/07231-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/07232-1"],"award-info":[{"award-number":["2012\/07232-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/20209-4"],"award-info":[{"award-number":["2014\/20209-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.expneurol.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T20:46:14Z","timestamp":1556138774000},"page":"12-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Monoaminergic regulation of nociceptive circuitry in a Parkinson's disease rat model"],"prefix":"10.1016","volume":"318","author":[{"given":"Ana Carolina Pinheiro","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri\u00e3 Benatti","family":"Berzuino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Sorrentino","family":"Hernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich Talamoni","family":"Fonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-6575","authenticated-orcid":false,"given":"Rosana Lima","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2019.04.015_bb0005","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2003.10.073","article-title":"Afferent pain pathways: a neuroanatomical review","volume":"1000","author":"Almeida","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0015","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov","volume":"24","author":"Barone","year":"2009","journal-title":"Disord"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","article-title":"Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry","volume":"7","author":"Basbaum","year":"1984","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM199110173251610","article-title":"Opiate analgesia. How central is a peripheral target?","volume":"325","author":"Basbaum","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0030","first-page":"323","article-title":"Opiate and stimulation-produced analgesia: the contribution of the monoamines","volume":"5","author":"Basbaum","year":"1983","journal-title":"Adv Pain Res. Ther."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0035","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.1523\/JNEUROSCI.1817-11.2011","article-title":"Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli","volume":"31","author":"Beaudry","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(82)90656-4","article-title":"Enkephalin immunoreactive stalked neurons and lamina IIb islet neurons in cat substantia gelatinosa","volume":"240","author":"Bennett","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0045","first-page":"80","article-title":"Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease","volume":"35","author":"Bertrand","year":"1997","journal-title":"Folia Neuropathol."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2019.04.015_bb0050","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.parkreldis.2008.04.015","article-title":"The 6-hydroxydopamine model: news from the past","volume":"14","author":"Blandini","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000386484","article-title":"The place of animal psychology in the development of psychosomatic research","volume":"1","author":"Broadhurst","year":"1960","journal-title":"Fortschr. Psychosom. Med."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.24054","article-title":"Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool","volume":"27","author":"Broen","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0070","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.21439","article-title":"Radicular and nonradicular back pain in Parkinson's disease: a controlled study","volume":"22","author":"Broetz","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/jn.1998.79.2.677","article-title":"Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons","volume":"79","author":"Budai","year":"1998","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0080","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neubiorev.2008.03.009","article-title":"Spinal glial activation contributes to pathological pain states","volume":"32","author":"Cao","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0085","doi-asserted-by":"crossref","first-page":"6383240","DOI":"10.1155\/2016\/6383240","article-title":"Restoring spinal noradrenergic inhibitory tone attenuates pain hypersensitivity in a rat model of Parkinson's disease","volume":"2016","author":"Cao","year":"2016","journal-title":"Neural Plast"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0095","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.27377","article-title":"Alteration of nociceptive integration in the spinal cord of a rat model of Parkinson's disease","volume":"33","author":"Charles","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0100","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-3959(94)00172-B","article-title":"The role of the basal ganglia in nociception and pain","volume":"60","author":"Chudler","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2008.03.053","article-title":"Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine","volume":"1213","author":"Chudler","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0028-3908(79)90102-3","article-title":"Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway","volume":"18","author":"Commissiong","year":"1979","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson's disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0130","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/brain\/awh102","article-title":"Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model","volume":"127","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0135","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archneurol.2008.2","article-title":"Pain as a nonmotor symptom of Parkinson disease","volume":"65","author":"Defazio","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0140","doi-asserted-by":"crossref","first-page":"e0153506","DOI":"10.1371\/journal.pone.0153506","article-title":"Top-down effect of direct current stimulation on the nociceptive response of rats","volume":"11","author":"Dimov","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2019.02.007","article-title":"Parkinson's disease and pain: modulation of nociceptive circuitry in a rat model of nigrostriatal lesion","volume":"315","author":"Domenici","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","article-title":"Neurotransmitters in nociceptive modulatory circuits","volume":"14","author":"Fields","year":"1991","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pain.2004.03.036","article-title":"Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors","volume":"110","author":"Flores","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0165","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/092986707781745550","article-title":"Noradrenaline in Parkinson's disease: from disease progression to current therapeutics","volume":"14","author":"Fornai","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00702-015-1370-z","article-title":"Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation","volume":"122","author":"Frosini","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2016.06.031","article-title":"Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease","volume":"283","author":"Gee","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.870010106","article-title":"Pain in Parkinson's disease","volume":"1","author":"Goetz","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0190","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0306-4522(91)90031-I","article-title":"The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression","volume":"42","author":"Gogas","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0195","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1074\/jbc.M113.458901","article-title":"Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors","volume":"288","author":"Gyoneva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0200","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0165-0173(98)00018-6","article-title":"Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB\/ATF proteins","volume":"28","author":"Herdegen","year":"1998","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0205","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cne.903130113","article-title":"Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation","volume":"313","author":"Herdegen","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0028-3908(01)00087-9","article-title":"Noradrenergic modulation of serotonin release in rat dorsal and median raph\u00e9 nuclei via alpha(1) and alpha(2A) adrenoceptors","volume":"41","author":"Hopwood","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","article-title":"The serotonergic system in Parkinson's disease","volume":"95","author":"Huot","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/0470869127.ch6","article-title":"Chronic pain and microglia: the role of ATP","volume":"261","author":"Inoue","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0225","series-title":"Principles of Neural Science","first-page":"385","article-title":"Pain and analgesia","author":"Jessel","year":"1991"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0230","first-page":"39","article-title":"Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?","volume":"91","author":"Kish","year":"2003","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0235","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbi.2011.12.002","article-title":"Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity","volume":"26","author":"Krabbe","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0240","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-007-0931-8","article-title":"Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?","volume":"199","author":"Lane","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0245","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","article-title":"Buspirone: what is it all about?","volume":"1461","author":"Loane","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","article-title":"Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage","volume":"33","author":"Luthman","year":"1989","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(99)02396-3","article-title":"The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum","volume":"855","author":"Magnusson","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0265","first-page":"338","article-title":"5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats","volume":"19","author":"Mahmoudi","year":"2011","journal-title":"Daru"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0165-6147(96)01013-9","article-title":"GABA and its receptors in the spinal cord","volume":"17","author":"Malcangio","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0275","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1476-5381.2009.00478.x","article-title":"Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes*","volume":"158","author":"Mantovani","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0280","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2006.07.003","article-title":"Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions","volume":"1112","author":"Matsubara","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0285","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0290","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1523\/JNEUROSCI.23-03-01026.2003","article-title":"Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats","volume":"23","author":"Milligan","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0295","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/0929867323666160122115057","article-title":"Serotonin 1A receptors on astrocytes as a potential target for the treatment of Parkinson's disease","volume":"23","author":"Miyazaki","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.nbd.2013.08.003","article-title":"Targeting 5-HT(1A) receptors in astrocytes to protect dopaminergic neurons in Parkinsonian models","volume":"59","author":"Miyazaki","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cne.902300112","article-title":"The cytoarchitectonic organization of the spinal cord in the rat. I. the lower thoracic and lumbosacral cord","volume":"230","author":"Molander","year":"1984","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fnsys.2014.00110","article-title":"Hemispheric differences in the mesostriatal dopaminergic system","volume":"8","author":"Molochnikov","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0315","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/jnnp.2008.145995","article-title":"Pain sensitivity and descending inhibition of pain in Parkinson's disease","volume":"80","author":"Mylius","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0320","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1734-1140(10)70264-4","article-title":"Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats","volume":"62","author":"Nayebi","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ncn3.12051","article-title":"Duloxetine increases the effects of levodopa in a rat model of Parkinson's disease","volume":"4","author":"Nishijima","year":"2016","journal-title":"Neurol. Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tins.2003.12.006","article-title":"How does Parkinson's disease begin? The role of compensatory mechanisms","volume":"27","author":"Obeso","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0335","doi-asserted-by":"crossref","first-page":"s12990","DOI":"10.1186\/s12990-015-0026-1","article-title":"Pain perception in acute model mice of Parkinson's disease induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)","volume":"11","author":"Park","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0340","series-title":"The Rat Brain in Stereotaxic Coordinates, the Rat Brain: In Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0345","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0350","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130050972","article-title":"Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects","volume":"144","author":"Prinssen","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0355","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2013.06.015","article-title":"Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease","volume":"248","author":"Prinz","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2003.12.001","article-title":"Quality of life and pain in Parkinson's disease: a controlled cross-sectional study","volume":"10","author":"Quittenbaum","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0365","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0370","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01250009","article-title":"Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA","volume":"59","author":"Reader","year":"1984","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00207450108986528","article-title":"Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine","volume":"109","author":"Rodrigues","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0380","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1126\/science.6121374","article-title":"Opiates and pain pathways: demonstration of enkephalin synapses on dorsal horn projection neurons","volume":"215","author":"Ruda","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0079-6123(08)64606-3","article-title":"Neurochemistry and neural circuitry in the dorsal horn","volume":"66","author":"Ruda","year":"1986","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0390","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/284472a0","article-title":"Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors","volume":"284","author":"Sanberg","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(08)62576-5","article-title":"Neurobiology of spinal nociception: new concepts","volume":"110","author":"Sandk\u00fchler","year":"1996","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0400","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbr.2013.10.035","article-title":"Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin","volume":"259","author":"Santiago","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0405","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0410","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(86)91446-0","article-title":"Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients","volume":"380","author":"Scatton","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0415","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","article-title":"Comorbidity of the nonmotor symptoms of Parkinson's disease","volume":"16","author":"Shulman","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0425","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/JMDH.S105857","article-title":"Pain management in patients with Parkinson's disease: challenges and solutions","volume":"9","author":"Skogar","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0430","doi-asserted-by":"crossref","first-page":"a009316","DOI":"10.1101\/cshperspect.a009316","article-title":"A guide to neurotoxic animal models of Parkinson's disease","volume":"1","author":"Tieu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0435","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s12035-018-1116-7","article-title":"Pain inhibits pain: an ascending-descending pain modulation pathway linking mesolimbic and classical descending mechanisms","volume":"56","author":"Tobaldini","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0440","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/archneur.63.12.1724","article-title":"Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline","volume":"63","author":"Tong","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0445","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0450","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12264-009-1023-z","article-title":"Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of parkinsonism","volume":"25","author":"Wang","year":"2009","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0455","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917691525","article-title":"Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease","volume":"13","author":"Wang","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0460","first-page":"1","article-title":"Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain","volume":"521","author":"Watkins","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0465","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2019.04.015_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","article-title":"Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease","volume":"97","author":"Xu","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0475","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.0711839105","article-title":"Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of parkinsonism","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0480","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10072-014-1993-0","article-title":"The heterogeneity of non-motor symptoms of Parkinson's disease","volume":"36","author":"Zhang","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2019.04.015_bb0485","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488619300780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488619300780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:49:47Z","timestamp":1762148987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488619300780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":97,"alternative-id":["S0014488619300780"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2019.04.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoaminergic regulation of nociceptive circuitry in a Parkinson's disease rat model","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}